CJJD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CJJD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net margin is calculated as Net Income divided by its Revenue. China Jo-Jo Drugstores's Net Income for the six months ended in Mar. 2024 was $-3.3 Mil. China Jo-Jo Drugstores's Revenue for the six months ended in Mar. 2024 was $76.0 Mil. Therefore, China Jo-Jo Drugstores's net margin for the quarter that ended in Mar. 2024 was -4.36%.
The historical rank and industry rank for China Jo-Jo Drugstores's Net Margin % or its related term are showing as below:
The historical data trend for China Jo-Jo Drugstores's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Jo-Jo Drugstores Annual Data | |||||||||||||||||||||
Trend | Mar15 | Mar16 | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | Mar24 | |||||||||||
Net Margin % | Get a 7-Day Free Trial | -4.95 | -6.10 | -1.94 | -14.21 | -2.74 |
China Jo-Jo Drugstores Semi-Annual Data | ||||||||||||||||||||
Sep14 | Mar15 | Sep15 | Mar16 | Sep16 | Mar17 | Sep17 | Mar18 | Sep18 | Mar19 | Sep19 | Mar20 | Sep20 | Mar21 | Sep21 | Mar22 | Sep22 | Mar23 | Sep23 | Mar24 | |
Net Margin % | Get a 7-Day Free Trial | -3.41 | -0.82 | -27.00 | -1.18 | -4.36 |
For the Pharmaceutical Retailers subindustry, China Jo-Jo Drugstores's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, China Jo-Jo Drugstores's Net Margin % distribution charts can be found below:
* The bar in red indicates where China Jo-Jo Drugstores's Net Margin % falls into.
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
China Jo-Jo Drugstores's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as
Net Margin | = | Net Income (A: Mar. 2024 ) | / | Revenue (A: Mar. 2024 ) |
= | -4.234 | / | 154.541 | |
= | -2.74 % |
China Jo-Jo Drugstores's Net Margin for the quarter that ended in Mar. 2024 is calculated as
Net Margin | = | Net Income (Q: Mar. 2024 ) | / | Revenue (Q: Mar. 2024 ) |
= | -3.31 | / | 75.967 | |
= | -4.36 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Jo-Jo Drugstores (NAS:CJJD) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Thank you for viewing the detailed overview of China Jo-Jo Drugstores's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Wei Hu | officer: Chief Operating Officer | HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY F4 310008 |
Pingfan Wu | director | HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY F4 310008 |
Jiangliang He | director | HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY NY 310008 |
Liu Yan | officer: Secretary | HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY, ZHEJIANG PROVIN F4 310008 |
Lei Liu | director, 10 percent owner, officer: CEO, Chairman of the Board | ROOM 507-513, 5TH FLOOR,A BUILDING MEIDU PLAZA, GONGSHU DISTRICT HANGZHOU F4 310011 |
Ming Zhao | director, 10 percent owner, officer: Chief Financial Officer | 1ST FLOOR, YUZHENG PLAZA, NO. 76, YUHUANGSHAN ROAD, HANGZHOU, ZHEJIANG PROVINCE F4 00000 |
Caroline Wang | director | HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY F4 310008 |
Hillhouse Investment Management, Ltd. | 10 percent owner | OFFICE #122, WINDWARD 3 BUILDING, REGATTA OFFICE PARK, WEST BAY ROAD, GRAND CAYMAN E9 KY1-9006 |
Li Lei | director, 10 percent owner, officer: CEO, Chairman of the Board | 511 NE 94TH STREET MIAMI SHORES FL 33138 |
Li Qi | director, 10 percent owner, officer: Secretary | ROOM 507-513, 5TH FLOOR, A BUILDING MEIDU PLAZA, GONGSHU DISTRICT HANGZHOU F4 310011 |
Zhimin Su | director | 3601B THE CENTER, 989 CHANGLE ROAD SHANGHAI F4 200031 |
Genghua Gu | director | 1ST FLOOR, YUZHENG PLAZA NO.76, YUHUANGSHAN ROAD HANGZHOU, ZHEJIANG PROVINCE F4 310002 |
Taihong Guo | director | 7TH FLOOR, QINGCHUNBAO GROUP NO. 555 XIXI ROAD HANGZHOU F4 310013 |
Tchaikovsky Bennet Price Jr | other: Former Director | 11601 WILSHIRE BOULEVARD, SUITE 2150, LOS ANGELES CA 90025 |
Marc Thomas Serrio | other: Former Director | P.O. BOX 91836 PASADENA CA 91109 |
From GuruFocus
By PRNewswire • 04-29-2024
By PRNewswire • 06-11-2024
By PRNewswire • 05-31-2024
By PRNewswire PRNewswire • 06-16-2023
By GuruFocus News • 10-15-2024
By PRNewswire • 09-26-2023
By PRNewswire PRNewswire • 02-02-2021
By PRNewswire PRNewswire • 04-18-2023
By PRNewswire • 02-27-2024
By PRNewswire PRNewswire • 01-19-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.